190 related articles for article (PubMed ID: 24463278)
1. Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target.
Ueno S; Lu J; He J; Li A; Zhang X; Ritz J; Silberstein LE; Chai L
Exp Hematol; 2014 Apr; 42(4):307-316.e8. PubMed ID: 24463278
[TBL] [Abstract][Full Text] [Related]
2. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.
Jeong HW; Cui W; Yang Y; Lu J; He J; Li A; Song D; Guo Y; Liu BH; Chai L
PLoS One; 2011 Apr; 6(4):e18372. PubMed ID: 21526180
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.
Cui W; Kong NR; Ma Y; Amin HM; Lai R; Chai L
Mod Pathol; 2006 Dec; 19(12):1585-92. PubMed ID: 16998462
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
5. Inferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia.
Almamun M; Kholod O; Stuckel AJ; Levinson BT; Johnson NT; Arthur GL; Davis JW; Taylor KH
Leuk Lymphoma; 2017 Sep; 58(9):1-12. PubMed ID: 28094574
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia.
Welch MD; Greene WK; Kees UR
Br J Haematol; 2013 Aug; 162(4):537-41. PubMed ID: 23772794
[TBL] [Abstract][Full Text] [Related]
7. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
Fears S; Chakrabarti SR; Nucifora G; Rowley JD
Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
[TBL] [Abstract][Full Text] [Related]
9. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
11. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
12. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.
Sarvaiya PJ; Schwartz JR; Hernandez CP; Rodriguez PC; Vedeckis WV
Am J Hematol; 2012 Oct; 87(10):969-76. PubMed ID: 22764095
[TBL] [Abstract][Full Text] [Related]
13. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.
Harder L; Eschenburg G; Zech A; Kriebitzsch N; Otto B; Streichert T; Behlich AS; Dierck K; Klingler B; Hansen A; Stanulla M; Zimmermann M; Kremmer E; Stocking C; Horstmann MA
J Exp Med; 2013 Oct; 210(11):2289-304. PubMed ID: 24081948
[TBL] [Abstract][Full Text] [Related]
14. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract][Full Text] [Related]
15. The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma.
Wang P; Zhang JD; Wu F; Ye X; Sharon D; Hitt M; McMullen TP; Hegazy SA; Gelebart P; Yang J; Ma Y; Lai R
Cell Signal; 2012 Oct; 24(10):1955-63. PubMed ID: 22743134
[TBL] [Abstract][Full Text] [Related]
16. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
17. SALL4 is a key regulator of survival and apoptosis in human leukemic cells.
Yang J; Chai L; Gao C; Fowles TC; Alipio Z; Dang H; Xu D; Fink LM; Ward DC; Ma Y
Blood; 2008 Aug; 112(3):805-13. PubMed ID: 18487508
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
Cocco C; Airoldi I
Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
[TBL] [Abstract][Full Text] [Related]
20. BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.
Rodríguez-Malavé NI; Fernando TR; Patel PC; Contreras JR; Palanichamy JK; Tran TM; Anguiano J; Davoren MJ; Alberti MO; Pioli KT; Sandoval S; Crooks GM; Rao DS
Mol Cancer; 2015 Dec; 14():214. PubMed ID: 26694754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]